| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INOGEN INC COM | 3,549,320 | 238,408,000 | 22.70% | ||
| 2 | VANGUARD INDEX FDS | 1,623,100 | 187,176,000 | 17.83% | ||
| 3 | COLUCID PHARMACEUTICALS INC COM | 3,156,563 | 114,899,000 | 10.94% | ||
| 4 | VANGUARD INTL EQUITY INDEX F | 2,101,000 | 100,722,000 | 9.59% | ||
| 5 | REATA PHARMACEUTICALS INC | 3,367,763 | 73,518,000 | 7.00% | ||
| 6 | IRHYTHM TECHNOLOGIES INC COM ADDED | 2,024,448 | 60,733,000 | 5.78% | ||
| 7 | CORVUS PHARMACEUTICALS INC COM | 3,224,046 | 46,104,000 | 4.39% | ||
| 8 | ACCELERON PHARMA | 1,240,173 | 31,649,000 | 3.01% | ||
| 9 | RA PHARMACEUTICALS INC | 2,031,562 | 30,859,000 | 2.94% | ||
| 10 | MERUS N V | 1,410,417 | 29,774,000 | 2.84% | ||
| 11 | SPECTRANETICS CORP | 1,179,122 | 28,889,000 | 2.75% | ||
| 12 | FLEXION THERAPEUTICS INC COM | 1,397,718 | 26,585,000 | 2.53% | ||
| 13 | KALVISTA PHARMACEUTICALS INC | 2,901,927 | 20,517,000 | 1.95% | ||
| 14 | APOLLO ENDOSURGERY | 1,456,972 | 17,716,000 | 1.69% | ||
| 15 | Nabriva Therapeutics AG | 2,326,544 | 13,866,000 | 1.32% | ||
| 16 | INVUITY INC | 1,318,448 | 7,581,000 | 0.72% | ||
| 17 | DERMIRA INC | 216,562 | 6,568,000 | 0.63% | ||
| 18 | WRIGHT MED GROUP N V | 4,622,032 | 6,101,000 | 0.58% | PRN | |
| 19 | Crispr Therapeutics | 223,317 | 4,524,000 | 0.43% | ||
| 20 | HTG MOLECULAR DIAGNOSTICS IN | 1,280,185 | 2,868,000 | 0.27% | ||
| 21 | XENON PHARMACEUTICALS INC | 127,563 | 982,000 | 0.09% | ||
| 22 | OPKO HEALTH INC | 259 | 2,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-002225, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
